The program was started at Peking University in 2013 and since has cured ofer 5,800 Chinese leukemia patients, based on haploid allogeneic hematopoietic stem cell transplantation. This original treatment program will now be transplanted to Shenzhen University, Department of Hematology, to also benefit Shenzhen leukemia patients.
China Bio news release, May 2, 2017